Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex.
作者信息
Pithadia D J, Treichel A M, Jones A M, Julien-Williams P, Machado T, Moss J, Darling T N
机构信息
Department of Dermatology, Uniformed Services University, Bethesda, MD, USA.
Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
出版信息
Br J Dermatol. 2020 Sep;183(3):588-589. doi: 10.1111/bjd.19124. Epub 2020 May 26.
Abstract
摘要
相似文献
1
Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex.在一组结节性硬化症患者中，与使用口服雷帕霉素作用机制靶点抑制剂相关的皮肤不良事件。
Br J Dermatol. 2020 Sep;183(3):588-589. doi: 10.1111/bjd.19124. Epub 2020 May 26.
2
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex.大麻二酚可提高结节性硬化症患者雷帕霉素靶蛋白抑制剂水平。
Pediatr Neurol. 2020 Apr;105:59-61. doi: 10.1016/j.pediatrneurol.2019.11.017. Epub 2019 Dec 9.
3
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.雷帕霉素逆转结节性硬化症小鼠模型的社交互动障碍。
Nat Commun. 2012;3:1292. doi: 10.1038/ncomms2295.
4
Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation.雷帕霉素哺乳动物靶点抑制剂在结节性硬化症和肾移植中的安全性考量
J Clin Pharmacol. 2015 Apr;55(4):368-76. doi: 10.1002/jcph.428. Epub 2014 Dec 30.
5
Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.西罗莫司治疗结节性硬化症儿童癫痫：一项随机对照试验。
Neurology. 2016 Sep 6;87(10):1011-8. doi: 10.1212/WNL.0000000000003077. Epub 2016 Aug 10.
6
Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.结节性硬化症相关癫痫中雷帕霉素的作用机制靶点（mTOR）
Pediatr Neurol. 2015 Mar;52(3):281-9. doi: 10.1016/j.pediatrneurol.2014.10.028. Epub 2014 Nov 20.
7
Management of side effects of mTOR inhibitors in tuberous sclerosis patients.结节性硬化症患者中mTOR抑制剂副作用的管理。
Pharmacol Rep. 2016 Jun;68(3):536-42. doi: 10.1016/j.pharep.2016.01.005. Epub 2016 Jan 22.
8
The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.雷帕霉素对结节性硬化症神经胶质小鼠模型神经发育缺陷和认知的产前和/或产后的差异作用。
Hum Mol Genet. 2012 Jul 15;21(14):3226-36. doi: 10.1093/hmg/dds156. Epub 2012 Apr 24.
9
Mammalian target of rapamycin inhibitors in a patient with polycystic kidney disease-1-tuberous sclerosis-2 contiguous gene syndrome.雷帕霉素哺乳动物靶点抑制剂治疗多囊肾病1型-结节性硬化症2型相邻基因综合征患者
Saudi J Kidney Dis Transpl. 2018 Nov-Dec;29(6):1475-1479. doi: 10.4103/1319-2442.248317.
10
Rapamycin and rapalogs for tuberous sclerosis complex.用于结节性硬化症的雷帕霉素及雷帕霉素类似物。
Cochrane Database Syst Rev. 2016 Jul 13;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub2.
本文引用的文献
1
mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex.雷帕霉素靶蛋白抑制剂治疗作为一种疾病修饰疗法用于结节性硬化症。
Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):365-373. doi: 10.1002/ajmg.c.31655. Epub 2018 Oct 11.
2
Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer.口腔黏膜炎与哺乳动物雷帕霉素靶蛋白抑制剂的相关性：发病机制、预防、治疗综述及其对转移性乳腺癌口腔实践的临床意义。
J Am Dent Assoc. 2018 Apr;149(4):291-298. doi: 10.1016/j.adaj.2017.10.024. Epub 2018 Feb 10.
3
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.依维莫司在结节性硬化症患者中的长期应用：EXIST - 2研究的四年期更新
PLoS One. 2017 Aug 9;12(8):e0180939. doi: 10.1371/journal.pone.0180939. eCollection 2017.
4
Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review.厄洛替尼治疗肺腺癌患者后出现的睫毛异常增长及头皮毛发改变：一例报告及文献综述
Exp Ther Med. 2016 Sep;12(3):1287-1292. doi: 10.3892/etm.2016.3460. Epub 2016 Jun 16.
5
Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights.表皮生长因子受体抑制剂诱发的痤疮样皮疹：文献综述与新见解
Skin Appendage Disord. 2015 Mar;1(1):31-7. doi: 10.1159/000371821. Epub 2015 Feb 13.
6
mTOR signaling promotes stem cell activation via counterbalancing BMP-mediated suppression during hair regeneration.在毛发再生过程中，mTOR信号传导通过平衡BMP介导的抑制作用来促进干细胞激活。
J Mol Cell Biol. 2015 Feb;7(1):62-72. doi: 10.1093/jmcb/mjv005. Epub 2015 Jan 20.
7
Mammalian target of rapamycin inhibitor-associated stomatitis.雷帕霉素靶蛋白抑制剂相关性口腔炎。
Future Oncol. 2013 Dec;9(12):1883-92. doi: 10.2217/fon.13.141.
8
Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects.接受西罗莫司治疗的肾移植受者的痤疮：临床、微生物学、组织学、治疗及发病机制方面
J Am Acad Dermatol. 2006 Jul;55(1):139-42. doi: 10.1016/j.jaad.2005.11.1072.
Zotero 插件